Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe

Hypertension is a worldwide epidemic that continues to grow, with a subset of patients responding poorly to current treatment available. This is especially relevant in Asia, which constitutes 61% of the global population. Hypertension in Asia is a unique entity that is often salt‐sensitive, nocturna...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Donna S.‐H., Wang, Tzung‐Dau, Buranakitjaroen, Peera, Chen, Chen‐Huan, Cheng, Hao‐Min, Chia, Yook Chin, Sukonthasarn, Apichard, Tay, Jam Chin, Teo, Boon Wee, Turana, Yuda, Wang, Ji‐Guang, Kario, Kazuomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Treatment and Management of Hypertension
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029571/
https://www.ncbi.nlm.nih.gov/pubmed/33305531
http://dx.doi.org/10.1111/jch.14120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029571/
https://www.ncbi.nlm.nih.gov/pubmed/33305531
http://dx.doi.org/10.1111/jch.14120

Ejemplares similares